博騰股份(300363.SZ):蘇州博騰生物製藥擬實施核心人員的股權激勵
格隆匯7月20日丨博騰股份(300363.SZ)公佈,為快速引進和吸納高端人才,充分調動公司二級控股子公司蘇州博騰生物製藥有限公司(“蘇州博騰”)管理層、研發人員及業務骨幹的工作積極性,增強經營管理層及核心骨幹人員風險共擔、成就共享的認同意識和事業凝聚力,促進公司基因細胞治療CDMO業務持續快速發展,結合目前實際情況以及未來持續、穩定發展的目標,蘇州博騰擬實施核心人員的股權激勵。蘇州博騰的股東重慶博信生物科技合夥企業(有限合夥)(“博信生物”)以0元的對價將其所持有的蘇州博騰7.76%股權(2200萬股)轉讓給此次股權激勵成立的各“員工持股平台”,激勵對象通過該“員工持股平台”參與本次股權激勵。
此次股權激勵實施前後,蘇州博騰股東及持股情況如下:


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.